Top News:

Lupin shares gain on launch of generic form of Celebrex

Shares of Lupin were trading about 1% higher at 1.30 pm IST on Thursday as the pharma major announced...

By: | Mumbai | Published: December 11, 2014 2:35 PM

On a day when benchmark indices were trading in the red, shares of Lupin were trading about 1% higher at 1.30 pm IST on Thursday as the pharma major announced the launch of generic version of Celebrex Capsules.

In an exchange release, Lupin said that it had earlier signed a licensing agreement with Pfizer Inc regarding Celebrex. Celebrex Capsules had annual US sales of$2.54 billion (IMS MAT September, 2014).

Celebrex helps to treat pain and inflammation caused by arthritis and other conditions.  

Tags: Lupin
Please Wait while comments are loading...

Go to Top